0001104659-23-119813.txt : 20231120 0001104659-23-119813.hdr.sgml : 20231120 20231120120801 ACCESSION NUMBER: 0001104659-23-119813 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231120 FILED AS OF DATE: 20231120 DATE AS OF CHANGE: 20231120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones Robert B CENTRAL INDEX KEY: 0001431759 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 231421704 MAIL ADDRESS: STREET 1: C/O ACURA PHARMACEUTICALS, INC. STREET 2: 616 N NORTH COURT CITY: PALATINE STATE: IL ZIP: 60067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0000786947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 110853640 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 CITY: PALATINE STATE: IL ZIP: 60067 BUSINESS PHONE: 847-705-7709 MAIL ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 STREET 2: . CITY: PALATINE STATE: IL ZIP: 60067 FORMER COMPANY: FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW DATE OF NAME CHANGE: 19920703 4 1 tm2331068-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-11-20 0 0000786947 ACURA PHARMACEUTICALS, INC ACUR 0001431759 Jones Robert B C/O ACURA PHARMACEUTICALS, INC. 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 0 1 0 0 President & CEO 0 Common Stock 2023-11-20 4 M 0 40000 A 643555 D Restricted Stock Unit (2021 Plan) 0.01 2023-11-20 4 M 0 40000 D Common Stock 40000 0 D Represents exchange of restricted stock units. Par value of $.01 was paid by Reporting Person upon exchange of Restricted Stock Units for stock. Not Applicable. 40,000 Restricted Stock Units were granted on March 16, 2022 and were 100% vested on December 31, 2022 /s/ Robert B. Jones 2023-11-20